Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

Autor: Cooper, Da, Steigbigel, Rt, Gatell, Jm, Rockstroh, Jk, Katlama, C, Yeni, P, Lazzarin, A, Clotet, B, Kumar, Pn, Eron, Je, Schechter, M, Markowitz, M, Loutfy, Mr, Lennox, Jl, Zhao, J, Chen, J, Ryan, Dm, Rhodes, Rr, Killar, Ja, Gilde, Lr, Strohmaier, Vullo, Vincenzo, Meibohm, Ar, Miller, Md, Hazuda, Dj, Nessly, Ml, Dinubile, Mj, Isaacs, Rd, Teppler, H, Nguyen, By, BENCHMRK STUDY TEAMS

Background: We evaluated the efficacy of raltegravir and the development of viral resistance in two identical trials involving patients who were infected with human immunodeficiency virus type 1 (HIV-1) with triple-class drug resistance and in whom a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acfd904b9414218980a2d17b85e46901
http://hdl.handle.net/11573/85775

Raltegravir with optimized background therapy for resistant HIV-1 infection.

Autor: Steigbigel RT (AUTHOR), Cooper DA (AUTHOR), Kumar PN (AUTHOR), Eron JE (AUTHOR), Schechter M (AUTHOR), Markowitz M (AUTHOR), Loutfy MR (AUTHOR), Lennox JL (AUTHOR), Gatell JM (AUTHOR), Rockstroh JK (AUTHOR), Katlama C (AUTHOR), Yeni P (AUTHOR), Lazzarin A (AUTHOR), Clotet B (AUTHOR), Zhao J (AUTHOR), Chen J (AUTHOR), Ryan DM (AUTHOR), Rhodes RR (AUTHOR), Killar JA (AUTHOR), Gilde LR (AUTHOR)

Publikováno v: New England Journal of Medicine. 7/24/2008, Vol. 359 Issue 4, p339-354. 16p.

Single-Cell RNA Sequencing of the T Helper Cell Response to House Dust Mites Defines a Distinct Gene Expression Signature in Airway Th2 Cells.

Autor: Tibbitt CA; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Stark JM; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Martens L; Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Ma J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Mold JE; Department of Cell and Molecular Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Deswarte K; VIB Center for Inflammation Research, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Oliynyk G; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Feng X; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Lambrecht BN; VIB Center for Inflammation Research, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., De Bleser P; Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Nylén S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Hammad H; VIB Center for Inflammation Research, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Arsenian Henriksson M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Saeys Y; Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium., Coquet JM; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden. Electronic address: jonathan.coquet@ki.se.

Publikováno v: Immunity [Immunity] 2019 Jul 16; Vol. 51 (1), pp. 169-184.e5. Date of Electronic Publication: 2019 Jun 20.